Goldman Sachs is initiating coverage of mid-cap life science REIT Alexandria Real Estate Equities ARE with a Buy rating and 12-month target price of $77, indicating a total return of 13.6%, including the 2.6% dividend yield.
“We arrive at our target price by assuming a premium to our forward NAV estimate of $70, given ARE's stable cash flows and top-tier assets clustered in barrier-to-entry markets,” Goldman Sachs writes.
“In short, Alexandria has one of the highest quality portfolios in the REIT industry with an above-average near-term growth profile.”
Alexandria Real Estate Equities closed Tuesday at $69.43.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in